Our Solutions
Innovative approaches to infectious disease challenges
Drug Discovery
Interface Laboratories is at the forefront of developing novel medications to combat some of the most persistent infectious disease challenges, focusing on:
- Fungal Infections: We are developing new antifungal compounds that target resistant strains of fungal pathogens, with particular focus on invasive fungal infections that affect immunocompromised patients.
- Parasitic Diseases: Our team is researching innovative antiparasitic drugs that offer improved efficacy and reduced side effects compared to current treatment options.
- Clostridium difficile Infection: We are pioneering targeted approaches to treat C. difficile while preserving the beneficial gut microbiome, reducing recurrence rates that plague current treatment protocols.
Our drug discovery platform integrates computational modeling, high-throughput screening, and precision medicinal chemistry to identify and optimize promising compounds with maximum therapeutic potential and minimal adverse effects.
Diagnostic Assay Development
Early and accurate diagnosis is critical for effective infectious disease management. Our diagnostic solutions include:
- Rapid Detection Systems: Point-of-care diagnostic tools that provide results in minutes rather than days.
- Multipathogen Panels: Comprehensive testing platforms that can simultaneously detect multiple fungal and bacterial pathogens from a single sample.
- Antimicrobial Resistance Markers: Advanced diagnostics that identify resistance patterns, enabling appropriate treatment selection from the outset.
Our diagnostic technologies leverage the latest advances in molecular biology, immunoassays, and biosensor technology to deliver accurate, rapid, and cost-effective diagnostic solutions for healthcare providers across various clinical settings.
Therapeutic Drug Monitoring
Optimizing antimicrobial treatment requires precise dosing and ongoing monitoring. Our therapeutic drug monitoring solutions provide:
- Precision Dosing Tools: Systems that help clinicians determine optimal initial dosing based on patient-specific factors.
- Real-time Monitoring: Technologies that allow for continuous or frequent assessment of drug levels to maintain therapeutic concentrations.
- Pharmacokinetic Modeling: Advanced algorithms that predict drug behavior in various patient populations, including those with compromised organ function.
Our therapeutic drug monitoring platforms are designed to maximize treatment efficacy while minimizing toxicity and the development of antimicrobial resistance, ultimately improving patient outcomes in the treatment of severe infections.
Collaborate With Us
Interested in our solutions or potential partnerships? We welcome the opportunity to discuss how Interface Laboratories can address your infectious disease challenges.
Contact Our Team